Treatment Update: New Options for HCV Nonresponders

[Guest guest]

CME/CE-Certified Treatment UpdateNew Options for HCV Nonresponders:Navigating

Emerging Data and Best Practicesfor Treatment-Experienced Patients

The Interactive Case Challenges and Virtual Presentations in this

CME/CE-certified Treatment Update provide a comprehensive review of the latest

data and best practices on management approaches for patients previously treated

unsuccessfully for chronic HCV infection. Downloadable slidesets are also

available for use as a self-study resource or in your own noncommercial

presentations. To access this Treatment Update, click here or select an activity

below.

Interactive Case Challenges

Treatment of a Genotype 1a Patient Not Achieving Full Virologic Suppression With

Peginterferon/Ribavirin at 24 WeeksBy H. Sjogren, MD, MPH, FACP

Optimizing Treatment Success of a Second HCV Regimen in a Patient With

Unsuccessful Initial Treatment With Peginterferon alfa-2a and RibavirinBy

G. Gish, MD

Virtual Presentations

Management of HCV NonrespondersBy Ira M. son, MD

Maintaining Patients on Treatment: Optimizing and Individualizing Retreatment

for SuccessBy Bruce R. Bacon, MD

Downloadable Slidesets

Management of HCV NonrespondersBy Ira M. son, MD

Maintaining Patients on Treatment: Optimizing and Individualizing Retreatment

for SuccessBy Bruce R. Bacon, MD

This Treatment Update is located online

at:http://clinicaloptions.com/Hepatitis/Treatment%20Updates/Treatment-Experience\

d%20HCV.aspx

Physicians:Jointly sponsored by Postgraduate Institute for Medicine and Clinical

Care Options, LLC.

Physician Assistants (Preapproved):This program was planned in accordance with

AAPA's CME Standards for Enduring Material Programs and for Commercial Support

of Enduring Material Programs.

Nurses:Nursing contact hours provided through the cosponsorship of Postgraduate

Institute for Medicine and Clinical Care Options, LLC. Postgraduate Institute

for Medicine is accredited as a provider of continuing nursing education by the

American Nurses Credentialing Center's Commission on Accreditation.

Treatment of a Genotype 1a Patient Not Achieving Full Virologic Suppression With

Peginterferon/Ribavirin at 24 WeeksRelease date: June 13, 2008Expiration date:

June 12, 2009

Optimizing Treatment Success of a Second HCV Regimen in a Patient With

Unsuccessful Initial TreatmentWith Peginterferon alfa-2a and RibavirinRelease

date: October 3, 2008Expiration date: October 2, 2009

Management of HCV NonrespondersRelease date: June 13, 2008Expiration date: June

12, 2009

Maintaining Patients on Treatment: Optimizing and Individualizing Retreatment

for SuccessRelease date: August 27, 2008Expiration date: August 26, 2009

Supported by an educational grant from Three Rivers Pharmaceuticals®.

CCO Hepatitis | RSS | Hepatitis Podcasts | Bookstore | Slideset Downloads

To ensure you receive Clinical Care Options educational materials by

email,please add info@... to your contacts or address book.

Copyright 2008 Clinical Care Options, LLC. All rights reserved. 1894 Preston

White Drive, Suite 110, Reston, VA 20191-5433

Not a member yet? Click here | Unsubscribe from all emails sent from CCO |

Manage email preferences